Effect and mechanism of propranolol on promoting osteogenic differentiation and early implant osseointegration

Abstract

The present study aimed to investigate the effect of β-receptor blocker propranolol on early osseointegration of pure titanium implants and the underlying molecular regulatory mechanisms. An implant osseointegration model using the tibial metaphysis of New Zealand rabbits was established. The rabbits were divided into control and low-, medium-and high-dose propranolol groups. The formation of implant osseointegration was detected by X-ray scanning. Mesenchymal stem cells (MScs) and osteoblasts (OBs) were isolated and cultured in vitro, isoproterenol was supplemented to simulate sympathetic action and propranolol was subsequently administrated. The effect of propranolol on cell proliferation and osteogenic differentiation were assessed by EdU, flow cytometry, alizarin red staining and alkaline phosphatase (ALP) detection. The expression levels of bone morphogenetic protein (BMP)2, RUNX family transcription factor (RunX)2, collagen (cOL)-1, osteocalcin (OcN) and β2-adrenergic receptor (AR) were detected by immunofluorescence, reverse transcription-quantitative PcR and western blot assay. Propranolol effectively promoted implant osseointegration in vivo, facilitated proliferation of OBs, inhibited proliferation of MScs and enhanced osteogenic differentiation of OBs and MScs. The calcium content and ALP activity of cells treated with propranolol were markedly higher than in the control group. Propranolol also elevated mRNA and protein expression levels of BMP2, RunX2, cOL-1 and OcN in tissue and cells, and decreased the expression of β2-AR. The present study demonstrated that the β-receptor blocker propranolol promoted osteogenic differentiation of OBs and MScs and enhanced implant osseointegration. The present study provided a novel insight into the application and regulatory mechanisms of propranolol.

Beta 2 Adrenergic Receptor Selective Antagonist Enhances Mechanically Stimulated Bone Anabolism in Aged Mice

“…Butax treatment may relieve sympathetic suppression of mechanically stimulated osteoblast differentiation in vivo, as predicted by the findings of in vitro studies using PRO ( 51 ) and ISO ( 52 ) to manipulate β‐adrenergic activity in osteoblastic cultures. Mechanically stimulated calcium signaling is known to enhance osteoblast proliferation and differentiation through PI3K/AKT, ERK/Elk1, and CaMK/CREB signaling pathways.…”

Predictive nomogram model for severe coronary artery calcification in end-stage kidney disease patients

“…Wu et al. [ 43 ] discovered that the β-receptor blocker propranolol increased the expression levels of osteogenesis-associated genes in New Zealand rabbits, such as bone morphogenetic protein (BMP2), RUNX family transcription factor (RunX2), collagen (COL-1), and osteocalcin (OCN). Consequently, this augmentation promotes the osteogenic differentiation of mesenchymal stem cells (MScs) and OBs.…”

Predictive Model for Severe Coronary Artery Calcification in ESKD Patients

“…Past research has established the presence of β2-adrenergic receptor (AR) on the surface of human osteoblasts (OBs), and it has been suggested that β2-AR agonists could potentially hinder the proliferation of OBs 40 . Wu et al 41 discovered that the β-receptor blocker propranolol increased the expression levels of osteogenesis-associated genes, such as bone morphogenetic protein (BMP2), RUNX family transcription factor (RunX2), collagen (COL-1), and osteocalcin (OCN). Consequently, this augmentation promotes the osteogenic differentiation of mesenchymal stem cells (MScs) and OBs.…”